LITERATURE REVIEW: IDENTIFICATION OF TYPES OF BIOMARKERS FOR THE DETECTION OF ACUTE KIDNEY DISEASE AND CHRONIC KIDNEY DISEASE

Authors

  • Putri Ayuni Alayyannur 1 Department of Occupational Health and Safety, Faculty of Public Health, Universitas Airlangga, Surabaya, East Java, Indonesia, 60115; 2 Occupational Health and Safety Management Research Group, Faculty of Public Health, Universitas Airlangga, Surabaya, East Java, Indonesia, 60115
  • Doni Hikmat Ramdhan Department of Occupational Health and Safety, Faculty of Public Health, Universitas Indonesia, Depok, West Java, Indonesia, 12345

Keywords:

Biomarkers, acute kidney disease, chronic kidney disease

Abstract

Kidney disease is one of the global public health problems having high mortality rates. Patients suffering from kidney disease have the risk of experiencing losses in the form of mental health and financial state. Further identification of kidney disease biomarkers needs to be conducted to accelerate diagnostic activities so that the treatment can be carried out more quickly. This study is a literature review which was conducted to explore types of biomarkers that can be used to detect acute kidney disease and chronic kidney disease. The literature search was conducted in September 2021. The research sources were taken from several databases, namely Science Direct, ProQuest, PubMed, and Google Scholar. There were 49,115 articles found in Science Direct database, 161,983 articles found in ProQuest, 9,749 articles found PubMed, and 45,850 articles found in Google Scholar.  Out of the entire database, only 21 articles met the inclusion criteria. The variables in this study were biomarkers, acute kidney disease, and chronic kidney disease. This literature review shows that the examination of biomarkers for acute kidney disease and chronic kidney disease can be done by taking urine and blood samples of the patient. There are 10 types of biomarkers that can be used to detect acute kidney disease and 41 types of biomarkers that can be used to detect chronic kidney disease. Acute kidney disease and chronic kidney disease can be diagnosed by examining the biomarkers present in the patient's body. The examination of biomarkers can reduce delays in the treatment of acute kidney disease and chronic kidney disease.

Downloads

Download data is not yet available.

References

1] Akin, D., Ozmen, S. and Yilmaz, M. E. (2017) ‘Hyaluronic Acid as a New Biomarker to Differentiate Acute Kidney Injury from Chronic Kidney Disease’, Iranian Journal of Kidney Diseases, 11(6), pp. 409–413.

2] Ascher, S. B. et al. (2021) ‘Urine Biomarkers of Kidney Tubule Health and Incident CKD Stage 3 in Women Living With HIV: A Repeated Measures Study’, Kidney Medicine, 3(3), pp. 395-404.e1.

3] Benito, S. et al. (2018) ‘Plasma Biomarker Discovery for Early Chronic Kidney Disease Diagnosis based on Chemometric Approaches using LC-QTOF Targeted Metabolomics Data’, Journal of Pharmaceutical and Biomedical Analysis, 149(1), pp. 46–56.

4] Benito, S. et al. (2019) ‘LC-QQQ-MS Routine Analysis Method for New Biomarker Quantification in Plasma Aimed at Early Chronic Kidney Disease Diagnosis’, Journal of Pharmaceutical and Biomedical Analysis, 169(1), pp. 82–89.

5] Bikbov, B. et al. (2020) ‘Global, Regional, and National Burden of Chronic Kidney Disease, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017’, The Lancet, 395(10225), pp. 709–733. doi: 10.1016/S0140-6736(20)30045-3.

6] Castro-Sesquen, Y. E. et al. (2020) ‘Use of Multiple Urinary Biomarkers for Early Detection of Chronic Kidney Disease in Sickle Cell Anemia Patients’, Blood, 136(1), pp. 1–30.

7] Chindarkar, N. S. et al. (2016) ‘Reference Intervals of Urinary Acute Kidney Injury (AKI) Markers [IGFBP7] · [TIMP2] in Apparently Healthy Subjects and Chronic Comorbid Subjects without AKI’, Clinica Chimica Acta, 452, pp. 32–37. doi: 10.1016/j.cca.2015.10.029.

8] Cho, M. H. (2020) ‘Pediatric Acute Kidney Injury: Focusing on Diagnosis and Management’, Childhood Kidney Diseases, 24(1), pp. 19–26. doi: 10.3339/jkspn.2020.24.1.19.

9] Crews, D. C. et al. (2019) ‘Burden, Access, and Disparities in Kidney Disease’, Kidney International, 95(2), pp. 242–248. doi: 10.1016/j.kint.2018.11.007.

10] Dąbrowska-Bender, M. et al. (2018) ‘The Impact on Quality of Life of Dialysis Patients with Renal Insufficiency’, Patient Preference and Adherence, 12(1), pp. 577–583. doi: 10.2147/PPA.S156356.

11] Ekrikpo, U. E. et al. (2018) ‘Chronic Kidney Disease in the Global adult HIV-Infected Population: A Systematic Review and Meta-Analysis’, PLoS ONE, 13(4), pp. 1–24. doi: 10.1371/journal.pone.0195443.

12] ElSadek, A. E. et al. (2020) ‘Kidney Injury Molecule-1/Creatinine as a Urinary Biomarker of Acute Kidney Injury in Critically Ill Neonates’, Journal of Pediatric Urology, 16(5), pp. 688.e1-688.e9.

13] Faisal, F. (2019) ‘Interleukin 18 (IL-18) Urin sebagai Deteksi Dini Gangguan Ginjal Akut pada Penderita Sepsis’, Collaborative Medical Journal, 2(1), pp. 20–26.

14] Gaitonde, D. Y., Cook, D. L. and Rivera, I. M. (2017) ‘Chronic Kidney Disease: Detection and Evaluation’, American Family Physician, 96(12), pp. 776–783.

15] Geng, J. et al. (2021) ‘The Value of Kidney Injury Molecule 1 in Predicting Acute Kidney Injury in Adult Patients: A Systematic Review and Bayesian Meta-Analysis’, Journal of Translational Medicine, 19(105), pp. 1–13. doi: 10.1186/s12967-021-02776-8.

16] Hollinger, A. et al. (2018) ‘Proenkephalin A 119-159 (Penkid) Is an Early Biomarker of Septic Acute Kidney Injury: The Kidney in Sepsis and Septic Shock (Kid-SSS) Study’, Kidney International Reports, 3(6), pp. 1424–1433.

17] Infodatin Kementerian Kesehatan Republik Indonesia (2017) Situasi Penyakit Ginjal Kronis. Jakarta: Kementrian Kesehatan Republik Indonesia.

18] Jiang, W. et al. (2021) ‘Novel Predictive Biomarkers for Acute Injury Superimposed on Chronic Kidney Disease’, Nefrologia, 41(2), pp. 165–173.

19] Jin, Y. et al. (2017) ‘Urinary Kidney Injury molecule-1 as an Early Diagnostic Biomarker of Obstructive Acute Kidney Injury and Development of a Rapid Detection Method’, Molecular Medicine Reports, 15(3), pp. 1229–1235.

20] Keskin, G. S. et al. (2019) ‘Relationship between Plasma YKL-40 Levels and Endothelial Dysfunction in Chronic Kidney Disease’, Turkish Journal of Medical Sciences, 49(1), pp. 139–146. doi: 10.3906/sag-1804-169.

21] Ko, H. Y. et al. (2021) ‘Cystatin C and Neutrophil Gelatinase-Associated Lipocalin as Early Biomarkers for Chronic Kidney Disease in Dogs’, Topics in Companion Animal Medicine, 45(1), pp. 1–6.

22] Lee, D. Y. et al. (2020) ‘Gamma-glutamyl Transferase Variability can Predict the Development of End-stage of Renal Disease: A Nationwide Population-based Study’, Scientific Reports, 10(1), pp. 1–9. doi: 10.1038/s41598-020-68603-0.

23] Li, Q. et al. (2020) ‘The Predictive Value of Urinary Kidney Injury Molecular 1 for the Diagnosis of Contrast-Induced Acute Kidney Injury after Cardiac Catheterization: A Meta-Analysis’, Journal of Interventional Cardiology, 2020, pp. 1–9. doi: 10.1155/2020/4982987.

24] Liu, Z. et al. (2020) ‘Discovery and Validation of miR-452 as an Effective Biomarker for Acute Kidney Injury in Sepsis’, Theranostics, 10(26), pp. 11963–11975.

25] Nabity, M. B. (2018) ‘Traditional Renal Biomarkers and New Approaches to Diagnostics’, Toxicologic Pathology, 46(8), pp. 999–1001. doi: 10.1177/0192623318800709.

26] Ostermann, M., Bellomo, R., et al. (2020) ‘Controversies in Acute Kidney Injury: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference’, Kidney International, 98(2), pp. 294–309. doi: 10.1016/j.kint.2020.04.020.

27] Ostermann, M., Zarbock, A., et al. (2020) ‘Recommendations on Acute Kidney Injury Biomarkers From the Acute Disease Quality Initiative Consensus Conference: A Consensus Statement’, JAMA Network Open, 3(10), pp. 1–17. doi: 10.1001/jamanetworkopen.2020.19209.

28] Parikh, C. R. et al. (2016) ‘Application of New Acute Kidney Injury Biomarkers in Human Randomized Controlled Trials’, Kidney International, 89(6), pp. 1372–1379.

29] Park, H. S. et al. (2019) ‘Urinary Neutrophil Gelatinase-associated Lipocalin as a Biomarker of Acute Kidney Injury in Sepsis Patients in The Emergency Department’, Clinica Chimica Acta, 495(June), pp. 552–555.

30] Permatasari, P. J. et al. (2018) ‘Serum Cystatin C dan Kreatinin dalam Mendiagnosis Gangguan Ginjal Akut pada Anak Sakit Kritis’, Sari Pediatri, 20(2), p. 95.

31] Schmidt, I. M. et al. (2021) ‘Cadherin-11, Sparc-related Modular Calcium Binding Protein-2, and Pigment Epithelium Derived Factor are Promising Non-invasive Biomarkers of Kidney Fibrosis’, Kidney International, 100(3), pp. 672–683.

32] Shchelochkov, O. A. et al. (2019) ‘Chronic Kidney Disease in Propionic Acidemia’, Genetics in Medicine, 21(12), pp. 2830–2835.

33] Simsek, A., Tugcu, V. and Tasci, A. I. (2013) ‘New Biomarkers for the Quick Detection of Acute Kidney Injury’, ISRN Nephrology, 2013(1), pp. 1–9. doi: 10.5402/2013/394582.

34] Srisawat, N. and Kellum, J. A. (2020) ‘The Role of Biomarkers in Acute Kidney Injury’, Critical Care Clinics, 36(1), pp. 125–140. doi: https://doi.org/10.1016/j.ccc.2019.08.010.

35] Tabata, T. et al. (2020) ‘Interleukin-24 is a Novel Diagnostic Biomarker for The Severity of Acute kidney Injury’, Medical Molecular Morphology, 53(2), pp. 115–123.

36] Tapper, M. et al. (2021) ‘Cystatin C, Vitamin D and Thyroid Function Test Profile in Chronic Kidney Disease Patients’, Diseases, 9(1), pp. 1–16. doi: 10.3390/diseases9010005.

37] Zhang, W. R. et al. (2020) ‘Kidney Damage Biomarkers and Incident CKD During Blood Pressure Reduction: A Case-Control Study within SPRINT’, Ann Intern Med, 169(9), pp. 610–618.

38] Zhou, X. et al. (2017) ‘A New Plasma Biomarker Enhance The Clinical Prediction of Postoperative Acute Kidney Injury in Patients with Hepatocellular Carcinoma’, Clinica Chimica Acta, 475(4), pp. 128–136.

39] Zulkifli et al. (2018) ‘Sensitivity and Specificity of Urine N-Acetyl- β -D-Glucosaminidase as an Early Biomarker For Acute Kidney Injury’, Bioscientia Medicina, 2(4), pp. 30–38.

Downloads

Published

2025-06-13

Issue

Vol. 21 No. 2 (2025)

Section

ARTICLES

License

Copyright (c) 2025 Putri Ayuni Alayyannur, Doni Hikmat Ramdhan

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.